Clinical trial
Prospective Cohort Evaluating the Determinants of Radiation-Induced Skin Complications in Patients With Head and Neck Cancer Receiving Preventive Photobiomodulation
NCT07899866 is registered in ClinicalTrials.gov with Hopital Forcilles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Evaluating the Determinants of Radiation-Induced Skin Complications in Patients With Head and Neck Cancer Receiving Preventive Photobiomodulation
- Lead sponsor
- Hopital Forcilles
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 2, 2026
- Completion date
- November 30, 2028
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Head and neck cancer patients receiving radiotherapy with preventive PBM
Adults with head and neck cancer treated with curative-intent external beam radiotherapy (exclusive or adjuvant, with or without concomitant chemotherapy) exposing the cervical skin, who receive preventive photobiomodulation as part of standard care.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Number of Participants With Grade 2 or Higher Radiation Dermatitis Assessed by NCI-CTCAE v5.0
Occurrence of radiation dermatitis of grade 2 or higher according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 5.0 (moderate to brisk erythema, moist desquamation mostly confined to skin folds and/or moderate edema, or worse), assessed at each PBM session (3 times per week). Clinical, demographic, tumor-related, treatment-related and PBM-related factors associated with this outcome will be identified by univariate analyses and multivariable logistic regression.
Lead sponsor's other trials
Hopital Forcilles, most recent start first.
+7 more trials See the organization page
Similar trials
Same condition (Radiodermatitis) and phase, most recent start first.
+8 more trials See the condition page